NAD+ auxotrophy is bacteriocidal for the tubercle bacilli

Catherine Vilchèze, Brian Weinrick, Ka Wing Wong, Bing Chen, William Jacobs

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Summary The human tubercle bacillus Mycobacterium tuberculosis can synthesize NAD+ using the de novo biosynthesis pathway or the salvage pathway. The salvage pathway of the bovine tubercle bacillus Mycobacterium bovis was reported defective due to a mutation in the nicotinamidase PncA. This defect prevents nicotinic acid secretion, which is the basis for the niacin test that clinically distinguishes M. bovis from M. tuberculosis. Surprisingly, we found that the NAD+de novo biosynthesis pathway (nadABC) can be deleted from M. bovis, demonstrating a functioning salvage pathway. M. bovis ΔnadABC fails to grow in mice, whereas M. tuberculosis ΔnadABC grows normally in mice, suggesting that M. tuberculosis can acquire nicotinamide from its host. The introduction of M. tuberculosis pncA into M. bovis ΔnadABC is sufficient to fully restore growth in a mouse, proving that the functional salvage pathway enables nicotinamide acquisition by the tubercle bacilli. This study demonstrates that NAD+ starvation is a cidal event in the tubercle bacilli and confirms that enzymes common to the de novo and salvage pathways may be good drug targets.

Original languageEnglish (US)
Pages (from-to)365-377
Number of pages13
JournalMolecular Microbiology
Volume76
Issue number2
DOIs
StatePublished - Apr 2010

Fingerprint

Mycobacterium bovis
Mycobacterium tuberculosis
NAD
Bacillus
Niacinamide
Niacin
Nicotinamidase
Starvation
Mutation
Enzymes
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Biology
  • Microbiology
  • Medicine(all)

Cite this

NAD+ auxotrophy is bacteriocidal for the tubercle bacilli. / Vilchèze, Catherine; Weinrick, Brian; Wong, Ka Wing; Chen, Bing; Jacobs, William.

In: Molecular Microbiology, Vol. 76, No. 2, 04.2010, p. 365-377.

Research output: Contribution to journalArticle

@article{64dc4e7d6a4c4e5f8fd0d584a4c47382,
title = "NAD+ auxotrophy is bacteriocidal for the tubercle bacilli",
abstract = "Summary The human tubercle bacillus Mycobacterium tuberculosis can synthesize NAD+ using the de novo biosynthesis pathway or the salvage pathway. The salvage pathway of the bovine tubercle bacillus Mycobacterium bovis was reported defective due to a mutation in the nicotinamidase PncA. This defect prevents nicotinic acid secretion, which is the basis for the niacin test that clinically distinguishes M. bovis from M. tuberculosis. Surprisingly, we found that the NAD+de novo biosynthesis pathway (nadABC) can be deleted from M. bovis, demonstrating a functioning salvage pathway. M. bovis ΔnadABC fails to grow in mice, whereas M. tuberculosis ΔnadABC grows normally in mice, suggesting that M. tuberculosis can acquire nicotinamide from its host. The introduction of M. tuberculosis pncA into M. bovis ΔnadABC is sufficient to fully restore growth in a mouse, proving that the functional salvage pathway enables nicotinamide acquisition by the tubercle bacilli. This study demonstrates that NAD+ starvation is a cidal event in the tubercle bacilli and confirms that enzymes common to the de novo and salvage pathways may be good drug targets.",
author = "Catherine Vilch{\`e}ze and Brian Weinrick and Wong, {Ka Wing} and Bing Chen and William Jacobs",
year = "2010",
month = "4",
doi = "10.1111/j.1365-2958.2010.07099.x",
language = "English (US)",
volume = "76",
pages = "365--377",
journal = "Molecular Microbiology",
issn = "0950-382X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - NAD+ auxotrophy is bacteriocidal for the tubercle bacilli

AU - Vilchèze, Catherine

AU - Weinrick, Brian

AU - Wong, Ka Wing

AU - Chen, Bing

AU - Jacobs, William

PY - 2010/4

Y1 - 2010/4

N2 - Summary The human tubercle bacillus Mycobacterium tuberculosis can synthesize NAD+ using the de novo biosynthesis pathway or the salvage pathway. The salvage pathway of the bovine tubercle bacillus Mycobacterium bovis was reported defective due to a mutation in the nicotinamidase PncA. This defect prevents nicotinic acid secretion, which is the basis for the niacin test that clinically distinguishes M. bovis from M. tuberculosis. Surprisingly, we found that the NAD+de novo biosynthesis pathway (nadABC) can be deleted from M. bovis, demonstrating a functioning salvage pathway. M. bovis ΔnadABC fails to grow in mice, whereas M. tuberculosis ΔnadABC grows normally in mice, suggesting that M. tuberculosis can acquire nicotinamide from its host. The introduction of M. tuberculosis pncA into M. bovis ΔnadABC is sufficient to fully restore growth in a mouse, proving that the functional salvage pathway enables nicotinamide acquisition by the tubercle bacilli. This study demonstrates that NAD+ starvation is a cidal event in the tubercle bacilli and confirms that enzymes common to the de novo and salvage pathways may be good drug targets.

AB - Summary The human tubercle bacillus Mycobacterium tuberculosis can synthesize NAD+ using the de novo biosynthesis pathway or the salvage pathway. The salvage pathway of the bovine tubercle bacillus Mycobacterium bovis was reported defective due to a mutation in the nicotinamidase PncA. This defect prevents nicotinic acid secretion, which is the basis for the niacin test that clinically distinguishes M. bovis from M. tuberculosis. Surprisingly, we found that the NAD+de novo biosynthesis pathway (nadABC) can be deleted from M. bovis, demonstrating a functioning salvage pathway. M. bovis ΔnadABC fails to grow in mice, whereas M. tuberculosis ΔnadABC grows normally in mice, suggesting that M. tuberculosis can acquire nicotinamide from its host. The introduction of M. tuberculosis pncA into M. bovis ΔnadABC is sufficient to fully restore growth in a mouse, proving that the functional salvage pathway enables nicotinamide acquisition by the tubercle bacilli. This study demonstrates that NAD+ starvation is a cidal event in the tubercle bacilli and confirms that enzymes common to the de novo and salvage pathways may be good drug targets.

UR - http://www.scopus.com/inward/record.url?scp=77951165552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951165552&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2958.2010.07099.x

DO - 10.1111/j.1365-2958.2010.07099.x

M3 - Article

C2 - 20199601

AN - SCOPUS:77951165552

VL - 76

SP - 365

EP - 377

JO - Molecular Microbiology

JF - Molecular Microbiology

SN - 0950-382X

IS - 2

ER -